Good News II was shortlisted for the first batch of medical material innovation tasks

Good News II was shortlisted for the first batch of medical material innovation tasks

December 15, 2022Notice from the General Office of the Ministry of Industry and Information Technology and the General Office of the National Medical Products Administration on organizing the "first batch" work of "unveiling the tasks of biomedical materials innovation".

existBiomedical materials are indispensable new materials for the production of medical devices required to diagnose, treat, repair and replace human tissues and organs or enhance their functions. They include polymer materials, metal materials, inorganic non-metallic materials, etc., and are of great significance to protecting the health of the people.

In order to accelerate the research, production and application of biomedical materials in my country, promote collaborative innovation in the upstream and downstream of biomedical materials, and better support the high-quality development of the medical device industry, the Ministry of Industry and Information Technology and the National Medical Products Administration jointly launched the work of announcing and appointing leaders for biomedical materials innovation tasks.

With strong technical innovation and industrial application capabilities,advancedTechnical indicators,MatureTechnical route,completePromotion and application plan,reasonableIn terms of funding budget, the comprehensive capabilities of the team that answers the call are strong. Under the guidance of the government and the recommendation of the competent department, they take the lead in applying, "answering the call and taking charge", introducing talents, increasing R&D investment, and optimizing the configuration and indicators involved in production.

The Ministry of Industry and Information Technology and the National Medical Products Administration commissioned a third-party professional organization to organize the selection, and the (first batch) list of "taking the lead" units was officially shortlisted and announced on July 19, 2023.

At this point, our unit has officially entered the "horse race" with other units that have won the bid for the same product, and started the year of tackling key issues for innovative figures in biomedical materials.